Trial ID 21318 | Maryland Oncology Hematology Trial ID 21318 – Maryland Oncology Hematology

Trial ID 21318

Trial Information - Phase III

A PHASE I-III, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE THERAPIES IN COHORTS OF PATIENTS SELECTED ACCORDING TO BIOMARKER STATUS, WITH LOCALLY ADVANCED, UNRESECTABLE, STAGE III NON-SMALL CELL LUNG CANCER 

Disease Specifics: NSCLC

Protocol ID: BO42777

Sponsor: Roche Laboratories, Inc.

Status: STAR Trial

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Lung

Status

STAR Trial

Sponsor

Roche Laboratories, Inc.

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology